Supernus Pharmaceuticals Inc. (SUPN)

25.67
NASDAQ : Health Technology
Prev Close 26.59
Day Low/High 25.30 / 26.62
52 Wk Low/High 24.77 / 49.47
Avg Volume 550.50K
Exchange NASDAQ
Shares Outstanding 52.45M
Market Cap 1.39B
EPS 2.10
P/E Ratio 13.71
Div & Yield N.A. (N.A)

Latest News

3 Profitable Small Biotech Names to Consider

3 Profitable Small Biotech Names to Consider

Exelixis Inc., ANI Pharmaceuticals and Supernus Pharmaceuticals should not need to raise more capital in the foreseeable future.

Three Stocks on the Move

Markets off to a decent start to the trading day with all the major indices up a half hour into trading. Some of the names I have profiled in recent months are on the move early today. Let's take a look at a few of these: T2 Biosystems after posting...

More Tax Reform Winners

More Tax Reform Winners

One way or another I continue to believe that some sort of tax legislation will be signed before the end of the year.

Market Goes on a 'Buy the Dip' Trip

Market Goes on a 'Buy the Dip' Trip

Stocks slowly recovering from early lows.

There's No Rush for the Exits So Far

There's No Rush for the Exits So Far

There's lots of negativity, but dip buyers are showing up.

Shark Bites: Even Without Health Care Vote, Market's Feeling Better

Shark Bites: Even Without Health Care Vote, Market's Feeling Better

Broad strength and good tone mark action.

4 Smaller Biotech Names Worth Researching

4 Smaller Biotech Names Worth Researching

Here's why to check out Dynavax Technologies as well Lexicon, Supernus and Acadia Pharmaceuticals.

4 Blue-Chip Health-Care Picks on Sale (and the Portfolio Is Up 163% Since 2006)

4 Blue-Chip Health-Care Picks on Sale (and the Portfolio Is Up 163% Since 2006)

Demographic trends that boosted big gains in prior years haven't gone away.

The Bulls Don't Have Enough Juice for 20,000

The Bulls Don't Have Enough Juice for 20,000

But here are 8 stocks that look good to me, right now.

Rev's Forum: Can the Market Find a Second Wind?

Rev's Forum: Can the Market Find a Second Wind?

This is the time of the year when many moves are made for tax reasons.

Big-Cap Tech Names, Biotechs, Oils Lifting Market

Big-Cap Tech Names, Biotechs, Oils Lifting Market

The number of new 12-month highs has climbed to 240.

Small Biotechs on My Shopping List

Small Biotechs on My Shopping List

These small-caps are woefully undervalued after getting shellacked in October.

Going on a Mini Biotech Binge Into the Weekend

Thanks to everyone who contributed to the conversation on the Daily Diary today. It was quite a lively bunch. I wish the market could have held earlier highs, but at least it was a positive end to a volatile trading week and a downright brutal one f...

Supernus Offers Super Small-Cap Potential

Supernus Offers Super Small-Cap Potential

Given the biotech's growth prospects and pipeline assets, its shares seem greatly undervalued.

Seeing the Same Old Patterns Ahead of Fed News

Seeing the Same Old Patterns Ahead of Fed News

Buyers expect a dovish Fed and are still trying to put money to work.

Shark Bites: 5 Stocks I Am Playing in This Choppy Action

Shark Bites: 5 Stocks I Am Playing in This Choppy Action

Despite the unsettled market, there are still some interesting picks out there.

Looks Like Pessimism Is on the Rise

But there's aggressive capital that wants to be spent.

Risky IPOs: Envivio, Supernus

Risky IPOs: Envivio, Supernus

IPO Desktop President Francis Gaskins believes both Envivio and Supernus are a little risky for investors.